We have investigated hemoglobin O Indonesia (HbO Ina ) in related ethnic populations of the Indonesian archipelago: 1725 individuals of the five ethnic populations of South Sulawesi (Bugis, Toraja, Makassar, Mandar, and Kajang) and 959 individuals of the neighboring islands, who were divided into five phylogenetic groups: (a) Batak; (b) Malay from Padang, Pakanbaru, and Palembang in the island of Sumatra; (c) Javanese-related populations (Java, Tengger, and Bali) from the islands of Java and Bali; (d) populations of the Lesser Sunda Islands of Lombok, Sumba, and Sumbawa; and (e) the Papuan-languagespeaking population of Alor Island. Nineteen individuals heterozygous for HbO Ina were identified from the Bugis, Toraja, Makassar, and Kajang ethnic populations, but none from the other populations. In all cases, the underlying mutation was found to be in codon 116 (GAG to AAG) of the α 1 -globin gene, resulting in the Glu116Lys amino acid change. The level of HbO in the 17 individuals plus 12 additional family members carrying the mutation was found to be 11.6 Ϯ 1.0%, significantly lower than the expected 17%-22%, indicating the instability of HbO.
Introduction
Hemoglobin O Indonesia (HbO Ina ) is a hemoglobin (Hb) variant that was first reported in the Bugis population of Sulawesi Island in Indonesia, and hence designated originally as hemoglobin Buginese-X (Lie Injo 1957; Lie Injo and Sadono 1957) . A phenotypically similar HbO was reported in an Iranian family (Rahbar et al. 1975) and in an Italian (Marinucci et al. 1978) family. In all of these cases, the mutation could be shown by tryptic digestion experiments to be associated with an amino acid change at residue 116 (Glu116Lys) of the α-globin chain. The underlying mutation, however, has been defined only in one case of undefined ethnic origin, a GAG to AAG base substitution at codon 116 of the α 1 -globin gene (Molchanova et al. 1994) .
Except for a few anecdotal mentions (Lie Injo 1957; Lie Injo and Sadono 1957) , the distribution of HbO Ina in related Indonesian populations has not been investigated. The Southeast Asian archipelago is inhabited by more than 350 ethnic populations. While these populations have distinct languages and cultural characteristics, with the exception of those of Papua/New Guinea and certain islands in east Indonesia, they are related to the Bugis in that they belong to the Malayo-Polynesian branch of the Austronesian linguistic family (Pelras 1996; Bellwood 1995) . The current ethnic diversity is believed to have arisen as the result of a progressive migration of a proto-Austronesian-speaking Southern Mongoloid ancestral population into a continuum of preexisting Melano-Austroloid populations, the major part of which took place between 5000 and 2500 years before present (Bellwood 1995) . Information with regard to the frequency of HbO in the populations and the variation of its molecular basis, if any, is of interest in relation to (a) the prehistoric migratory origin of the populations, and (b) the possible medical relevance of the mutation as a modifier of the phenotypic expression of -thalassemia mutations (Weatherall and Clegg 1981) , which are common in the archipelago with carrier frequency ranging from 3% to more than 10% in certain ethnic populations (Sofro 1995) .
We have accordingly investigated HbO in five closely related populations of South Sulawesi (Bugis, Toraja, Makassar, Mandar, and Kajang), and in populations of the neighboring islands, which were divided into five phylogenetic groups: (a) Batak; (b) Malay-related populations of Padang, Pakanbaru, and Palembang, all on the island of Sumatra; (c) Javanese-related populations from Java, Tengger, and Bali; (d) populations of the Lesser Sunda Islands of Lombok, Sumba, and Sumbawa; and (e) the Papuan-language-speaking population of the Alor island.
Subjects and methods
Blood samples. Venous blood samples (5-10ml) were collected with informed consent from 1725 normal individuals of the Toraja (409), Makassar (361), Bugis (628), Mandar (238), and Kajang (89) ethnic populations. The Makassar, Bugis, Toraja, Mandar, and Kajang have distinct languages and cultural characteristics (Pelras 1996) , but inhabit neighboring regions in the southern part of Sulawesi island in Indonesia (Fig. 1 ). This study was approved by the Human and Medical Ethics Committee of the University of Hasanuddin (No 02/DPE-K/99). DNA samples from 959 individuals of other ethnic populations of the Indonesian archipelago (123 Batak, 263 Malay, 216 Javanese-related, 297 of the Lesser Sunda islands, and 60 Alor) are from the collections of the Inter University Centre for Biotechnology of the University of Gadjah Mada and of the Eijkman Institute, collected as part of a larger program in the study of the population structure and genome diversity of the Indonesian archipelago. All samples were collected using sodium-ethylenediaminetetraacetate (EDTA) (1.5 mg/ml final concentration) as an anticoagulant.
Hematological study and hemoglobin analysis. Hematological data [hemoglobin concentration, hematocrit, red-blood-cell count, and mean cell volume (MCV)] were obtained using an automatic cell counter (Cobas Micros OT 18; Roche, Basel, Switzerland) . The presence of abnormal hemoglobin was examined by the electrophoretic examination of hemolysate using a Titan Gel kit (Helena Laboratories, Beaumont, TX, USA) on cellulose acetate at pH 8.6 (Tris EDTA-boric acid buffer; Helena Laboratories) (Fig. 2a) . The levels of HbA 2 and HbO were quantitated following chromatography on diethylaminoethanyl (DEAE) cellulose using the Hemoglobin A 2 Micro Column (Bio-Rad, Hercules, CA, USA). HbO co-elutes with HbA 2 in this microcolumn, but their relative amounts could be determined from the cellulose acetate electrophoretic pattern, employing a Bio-Rad Model GS-700 Imaging Densitometer for the quantitation of each. The accuracy and reproducibility of this procedure was validated using a BioRad Variant hemoglobin testing system ( -thalassemia short program), which became available toward the end of this study; HbO and HbA 2 are well separated in this analyzer (Fig. 2b) . Eight of the last samples collected were quantitated for HbO by using the Bio-Rad Variant hemoglobin testing system only. The stability of HbO was evaluated by a thermal stability test (Brozovic and Henthorn 1995) and isopropanol test (Carrell and Kay 1972) .
Strategy for the detection and mapping of the HbO Ina mutation. DNA was extracted from peripheral blood leukocytes essentially as described in the Puregene DNA extraction kit (Gentra, St. Paul, MN, USA), and used for polymerase chain reaction (PCR) analysis to specifically amplify 122-and 117-bp fragments of the α 1 -and α 2 -globin genes, respectively (Fig. 3a) . Three primers were employed: a specific forward primer for each of the α-globin genes Fig. 1 . The Indonesian archipelago and ethnic populations investigated in this study. The insert shows the geographical relationships among the five ethnic populations of South Sulawesi (α 1 11031F or α 2 7218F), and a common reverse primer (α 1 11152R ϭ α 2 7334R), in which a nucleotide in the sequence has been modified to create a restriction site for HinfI at the position of codon 116 in the PCR-amplified α 1 -and α 2 -globin gene fragments (Fig. 3a) . Digestion of the PCR products from the normal α 1 -and α 2 -globin genes with HinfI produces 98-and a 24-bp fragments, and 93-and 24-bp fragments, respectively. The HinfI restriction site disappears if there is a mutation at codon 116 (Fig. 3b) .
DNA sequencing. Amplified fragments of the α 1 -globin gene described above were cloned into Escherichia coli DH5α using the pGEM-T vector system (Promega, Madison, WI, USA). The purified recombinant plasmid was used as the template in the sequencing of the insert in an ABI 377A sequencer employing dye terminator sequencing (Perkin Elmer, Foster City, CA, USA) with the T7 sequencing primer. The detection and mapping of the HbO Ina mutation by polymerase chain reaction-restriction fragment length polymorphism. The strategy deviced (a) involved separate and specific amplifications of the α 1 -and α 2 -globin gene fragments. α 2 7218F and α 1 11031F are specific forward primers for the amplification of the α 2 -and α 1 -globin gene fragments, respectively. α 2 7334R is identical to α 1 11152R, and is a common reverse primer containing a mismatch (G/T) to create a restriction site for HinfI enzyme at codon 116. Results obtained from representative samples are shown as an illustration (b). HinfI digestion of the amplified normal α 2 -globin gene fragment (lane 2) produces a 93-and a 24-(not seen) bp fragment (lane 3). The digestion of the normal α 1 -globin gene fragment (lane 4) gives a 98-and a 24-(not seen) bp fragment (lane 5). HbO Ina heterozygotes (lane 6) were found to produce a 98-(for α 1 -globin) and a 24-bp fragment, and also a 122-bp uncut fragment of the α 1 -globin gene. The upper bands in lanes 3, 5, and 6 (239 and 209 bp) are HinfI digestion products of an internal control (a 448-bp DNA fragment) added to the reaction mixture (lanes 2 and 4) to monitor the completeness of the digestion. The mutation of codon 116 (GAG to AAG) of the α 1 -globin gene was confirmed by direct sequencing in an ABI 377A sequencer (c); Ø indicates the site of the mutation Results A total of 1725 phenotypically normal individuals from the five major ethnic populations of the southern region of the island of Sulawesi (Fig. 1) were examined for HbO. The initial electrophoretic screen (Fig. 2a) revealed 19 individuals with HbO (Table 1) . Of these individuals, 10 were of the Toraja ethnic population (n ϭ 409; 1.2% allele frequency), one was Makassar (n ϭ 361; 0.1% allele frequency), five were Bugis (n ϭ 628; 0.4% allele frequency), and three were Kajang (n ϭ 89; 1.7% allele frequency).
The 19 individuals with HbO were further examined to confirm that the underlying mutation was indeed associated with codon 116, and, at the same time, to investigate whether the mutation was on the α 1 -or the α 2 -globin genes. Using the strategy outlined in Fig. 3a , all 19 cases were found to be associated with a point mutation on codon 116 of the α 1 -globin gene (Fig. 3b) . The mutation was confirmed by DNA sequencing to be a GAG to AAG base substitution (Fig. 3c ), resulting in a glutamic acid to lysine amino acid replacement (Glu116Lys). Employing the PCRrestriction fragment length polymorphism strategy above, 959 individuals from five other phylogenetic groups of the Indonesian populations were screened for the HbO mutation. However, the analysis did not reveal any HbO-positive individual (Table 1) .
We are interested in the phenotypic expression of the Glu116Lys amino acid replacement in the α-globin molecule. To increase the number of cases available for this part of the study, we screened family members of the initial 19 HbO-heterozygotic individuals and found 13 more cases. As shown in Table 2 , all but two of the 32 individuals with the HbO mutation exhibited normal or near normal hematological values, with the hemoglobin level ranging from 11.2 to 17.4 g/dl, a red blood cell count of 4.1 to 5.8 ϫ 10 12 /l, a hematocrit value of 33.7% to 51.2%, and mean cell volume (MCV) of 77 to 92 fl. One of the two exceptions was patient UP-410, who had a hemoglobin level of 10.3 g/dl, a hematocrit value of 30.7%, and MCV of 68 fl, and who in the blood smear evaluation showed microcytic hypochrome red blood cells. This patient, however, had a serum ferritin level of 4.3 µg/l, indicating iron deficiency. The other exception was patient UP-519, who had a normal Hb level but a low MCV value, indicating that this individual was either an α-or -thalassemia carrier. We note that while the hemoglobin level in the HbO-carrying individuals was mostly within the normal range, in a number of cases it was in fact at the lower end of or just below the range.
The mean HbO level was found to range from 10.1% to 13.8% of the total hemoglobin with a mean Ϯ SD of 11.6 Ϯ 1.0%, except for patients UP-1015 and KJG-16, who showed high HbO levels of 17.5% and 19.2%, respectively, and patient TRJ-21, who had an unusually low HbO level of 4.5%. The HbO levels in these three individuals have been confirmed by high-performance liquid chromatography (HPLC) using the Bio-Rad Variant hemoglobin testing system. The relatively high levels of HbO in patients UP-1015 and KJG-16 might be due to its co-inheritance with an α-thalassemia mutation. The reduced production of α-globin chain in α-thalassemia would give the α OIna -globin chains a higher probability of forming HbO. We have tested both UP-1015 and KJG-16 for the Southeast Asian α-globin gene deletion, which accounts for approximately 90% of the α-thalassemia mutations in the neighboring Southeast Asian countries (Ko et al. 1999) . The mutation could not be detected in these two cases, but the possibility of other α-globin defects still cannot be discounted. The low level of HbO in TRJ-21 could be caused by the co-inheritance of the HbO mutation with a -thalassemia mutation. However, DNA analysis for -globin gene defects could not detect any of the 19 most common -thalassemia mutations in Indonesia (Setianingsih et al. 1998) . It is interesting to note that the mother of TRJ-21 showed a HbO level of 13%, while the father showed normal red cell indices and hemoglobin pattern.
The hemoglobin analysis using the Bio-Rad Variant hemoglobin testing system showed a small peak at about 4 min in addition to the HbO peak at 4.9 min. This small peak was not found in the normal individuals (Fig. 2b) , and thus is presumably HbA 2 O (α Glu116Lys 2 δ 2 ). The HbO was stable (data not shown) in both the thermal stability test (Brozovic and Henthorn 1995) and the isopropanol test (Carrell and Kay 1972) .
Discussion
The present investigation represents the most extensive molecular epidemiological study of HbO that has been carried out to date, and it has revealed several interesting observations. First, our results provide evidence that, while on the one hand the distribution of HbO is confined to the ethnic populations of South Sulawesi, this hemoglobinopathy, originally designated hemoglobin Buginese-X, is in fact not restricted to the Bugis population. Indeed, the allele frequency was found to be 0.4% for the Bugis, only slightly higher than the level in the phylogenetically related Makassar population (0.1%), but significantly lower than the levels in the Toraja population (1.2%) or the small, isolated Kajang population (1.7%). This observation is of interest in terms of the phylogenetic relationships among the four ethnic populations and their relation to the other populations of the archipelago.
The populations of South Sulawesi investigated in the present study include three of the major ethnic populations of the archipelago, after the Javanese and Sundanese of the island of Java (population 75 and 27 million, respectively) and the Malay of the east coast of Sumatra and the Malaysian peninsula (population size approx. 25 million), with the population for the Bugis, Makassar, and Toraja being 3.5, 1.6, and 0.5 million, respectively (Grimes 1999) . Together with the Mandar (population 136,000) and the minor Kajang population (45,000), they inhabit neighboring regions in South Sulawesi (Fig. 1) but have distinct languages and cultural characteristics.
The finding of HbO in four populations of South Sulawesi but not in other populations of the archipelago suggests that the mutation occurred relatively recently, dur- Normal ranges are: Hb -male 13.0-16.0 g/dl, female 12.0-14.0 g/dl; red blood cell count -male 4.5-6.5 ϫ 10 12 /µl, female 4.0-6.0 ϫ 10 6 /µl; Hematocrit -male 40.0-48.0%, female 37.0-43.0%; MCV -82-92 fL; HbA 2 : Ͻ3.5%; Ferritin Ͻ12 µg/l ϭ iron deficiency. Bold values are outside the normal range UP-029 and UP-030 are siblings; UP-1014 and UP-1015 are sister and father of UP-376, respectively; UP-516 to UP-519 are children of UP-512; UP-522 is a child of UP-515; UP-523 to UP-525 are siblings; UP-1037 and UP-1038 are children of UP-528 HbO, hemoglobin O; MCV, mean cell volume; n.d., not determined a HbA 2 was seen in the electrophoresis gels, but the Bio-Rad Model GS-700 Imaging Densitometer could not measure the very low levels ing the early settlement of the southern region of Sulawesi Island by proto-Austronesian-speaking ancestors, perhaps, according to archeological data, some 3000 years ago (Bellwood 1995) . The fact that in 19 independent cases examined the causal mutation was found to be the same, i.e., a GAG to AAG substitution at codon 116 of the α 1 -globin gene (Glu116Lys), is consistent with this suggestion, and further suggests that the HbO mutation has occurred only once. While further study to identify the α-globin gene haplotypes associated with the HbO mutation is required for a definitive proof of a single origin, the fact that the mutation could not be found outside South Sulawesi, either in Indonesia (this study) or in neighboring Southeast Asia (Huisman et al. 1996 ) strongly argues for the hypothesis.
Our recent phylogenetic analysis of 28 ethnic population of the Indonesian archipelago based on the sequence polymorphism of the hypervariable region 1 (HVR 1) of the control D-loop region of the mtDNA (P. Pramoonjago and S. Marzuki, unpublished observation) showed clustering of the Austronesian-language-speaking populations of the archipelago into three clades. The Bugis and the Makassar are closely related and belong to a phylogenetic cluster. The Toraja, on the other hand, belong to a separate cluster, together with the Palembang and Banjar populations of South Sumatra and South Kalimantan. The high frequency of HbO in the Toraja (1.2%) relative to the Bugis and Makassar suggests that the origin of the mutation was in the Toraja population and that it spread to the Bugis and Makassar presumably through inter-population marriages, even though such marriages were rare in the past.
The finding of a high prevalence of HbO in the Kajang population is interesting but not easy to interpret. The population is a self-isolated religious community of only 45,000 living in a closed area of 129 km 2 . Linguistically, the population speaks the Konjo language, which is related to, although distinct from, the Makassar language. One interpretation of our result, therefore, is that the Kajang population was derived from the Toraja but adopted the Konjo language of the neighboring populations at some stage.
A phenotypically similar HbO has been reported in an Iranian family (Rahbar et al. 1975) and in an Italian (Marinucci et al. 1978) family. Although the exact mutation responsible for this HbO phenotype has not been defined, electrophoretic analysis of tryptic digests of the -globin chain did indicate a mutation similar to that observed in the South Sulawesi populations, i.e., a glutamic acid to lysine substitution at amino acid residue 116. A possibility thus exists that the HbO mutation is actually of a Middle Eastern origin and that it was introduced to South Sulawesi by Persian traders, perhaps soon after a.d. 1000, during the early phase of the introduction of Islam to the archipelago. This possibility, however, is remote because while the Bugis and the Makassar who inhabit the coastal region were converted through interactions with traders (Pelras 1996) , the Toraja population, in which the HbO frequency is significantly higher, lived in isolation until quite recently in mountainous inland of South Sulawesi; most of the Torajas remained animists until the end of the last century.
Our results are also of interest in terms of the phenotypic expression of the HbO mutation. The replacement of negatively charged glutamic acid by positively charged lysine at residue 116 is structurally significant and thus could potentially lead to a functional or assembly defect. The HbO level in all but two of our cases was in fact found to be significantly lower (10.1% to 13.8%) than that expected from a stable α 1 -globin variant; stable α 1 -variants have been reported to be present in the range of 16.9% to 22.5% (Molchanova et al. 1994) . The level of HbO has been determined previously in two studies only. In one study involving two families, it was reported to be in the range of 16.4% to 28.5% (Marinucci et al. 1978) . However, the level of HbO in this early study was not properly determined because of the inability to separate HbO Ina from HbA 2 by the electrophoretic procedure available. In the other study of a single case (Weatherall and Clegg 1981) , the level (8.4%) was closer to that found in the present study. In our study, the HbO level was measured accurately by two independent procedures; in both procedures (electrophoretic analysis on cellulose acetate and HPLC analysis in the Variant hemoglobin testing system), the HbO was well separated from HbA 2 .
In the present study, we showed that HbO is stable in vitro, consistent with the previous study of Molchanova et al. (1994) . An α1-globin gene carrying a HbO mutation is transcribed normally, and its mRNA represents around 21% of the total Hb mRNA (Molchanova et al. 1994) . Our hemoglobin analysis data, therefore, suggest that the HbO mutation is associated with instability of either the α OIna -globin chain or with less efficient assembly of the hemoglobin in vivo, which has been shown to be one of the consequences of the -globin Glu26Lys amino acid changes associated with the HbE mutation (Huisman 1997) . Indeed, in 8 out of 32 cases investigated in the present study, the Hb level was found to be either in the lower end of the normal range (2 cases) or slightly below (6 cases). This suggestion is supported by the extremely low level of HbA 2 seen in most of our patients, and is consistent with the milder phenotype of homozygous -thalassemia observed in one individual, who carried a heterozygote HbO mutation as well (Weatherall and Clegg 1981) . We are continuing our search for individuals homozygous for HbO to study further the functional abnormalities associated with this mutation, and for individuals with HbO/ -thalassemia to investigate whether HbO ameliorates the clinical expression ofthalassemia mutations.
